(Q39427565)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173567%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Sensitivity of cervical carcinoma cells to vesicular stomatitis virus-induced oncolysis: potential role of human papilloma virus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173567%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

human papilloma virus

object named as

human papilloma virus

1 reference

Fabrice Le Boeuf

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173567%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Nima Niknejad

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173567%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jiahu Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173567%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Johanne I Weberpals

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173567%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jim Dimitroulakos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173567%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

11 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173567%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173567%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173567%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173567%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

E204-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22173567%20AND%20SRC:MED&resulttype=core&format=json

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

18 January 2020

cites work

1 reference

Classification of papillomaviruses

21 January 2018

1 reference

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

The biological properties of E6 and E7 oncoproteins from human papillomaviruses.

21 January 2018

1 reference

Oncogenic activities of human papillomaviruses

21 January 2018

1 reference

The role of TP53 in Cervical carcinogenesis.

21 January 2018

1 reference

Human papillomavirus E6 and E7: proteins which deregulate the cell cycle

21 January 2018

1 reference

The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha

21 January 2018

1 reference

21 January 2018

Cancer statistics, 2000.

1 reference

Oncolytic viruses: what's next?

21 January 2018

1 reference

Recent progress in the battle between oncolytic viruses and tumours

21 January 2018

1 reference

From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development

21 January 2018

1 reference

Viruses as anticancer drugs

21 January 2018

1 reference

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial

21 January 2018

1 reference

The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma

21 January 2018

1 reference

Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

21 January 2018

1 reference

Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas

21 January 2018

1 reference

Phase I clinical trial of locoregional administration of the oncolytic adenovirus ONYX-015 in combination with mitomycin-C, doxorubicin, and cisplatin chemotherapy in patients with advanced sarcomas

21 January 2018

1 reference

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

21 January 2018

1 reference

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

21 January 2018

1 reference

Vesicular stomatitis virus: a potential therapeutic virus for the treatment of hematologic malignancy

21 January 2018

1 reference

Functional role of type I and type II interferons in antiviral defense

21 January 2018

1 reference

Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis

21 January 2018

1 reference

VSV-tumor selective replication and protein translation

21 January 2018

1 reference

Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus

21 January 2018

1 reference

Evaluation of an attenuated vesicular stomatitis virus vector expressing interferon-beta for use in malignant pleural mesothelioma: heterogeneity in interferon responsiveness defines potential efficacy

21 January 2018

1 reference

Expression of IFN-beta enhances both efficacy and safety of oncolytic vesicular stomatitis virus for therapy of mesothelioma

21 January 2018

1 reference

Role of nucleoporin induction in releasing an mRNA nuclear export block

21 January 2018

1 reference

Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus

21 January 2018

1 reference

HPV: from infection to cancer

21 January 2018

1 reference

HPV E6 down-regulation and apoptosis induction of human cervical cancer cells by a novel lipid-soluble extract (PE) from Pinellia pedatisecta Schott in vitro

21 January 2018

1 reference

Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow

21 January 2018

1 reference

The antiviral potential of interferon-induced cotton rat Mx proteins against orthomyxovirus (influenza), rhabdovirus, and bunyavirus.

21 January 2018

1 reference

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

21 January 2018

1 reference

Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways

21 January 2018

1 reference

The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon

21 January 2018

1 reference

Oncolytic viruses: a novel form of immunotherapy

21 January 2018

1 reference

Vesicular stomatitis virus: re-inventing the bullet

21 January 2018

1 reference

Synergistic interaction between oncolytic viruses augments tumor killing

21 January 2018

1 reference